NovoCure
NVCR
NVCR
218 hedge funds and large institutions have $1.37B invested in NovoCure in 2023 Q4 according to their latest regulatory filings, with 45 funds opening new positions, 84 increasing their positions, 54 reducing their positions, and 50 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
8% less capital invested
Capital invested by funds: $1.49B → $1.37B (-$118M)
10% less first-time investments, than exits
New positions opened: 45 | Existing positions closed: 50
13% less call options, than puts
Call options by funds: $30.9M | Put options by funds: $35.4M
Holders
218
Holding in Top 10
3
Calls
$30.9M
Puts
$35.4M
Top Buyers
| 1 | +$26.4M | |
| 2 | +$26.1M | |
| 3 | +$15.1M | |
| 4 |
BlackRock
New York
|
+$13.9M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$11.6M |
Top Sellers
| 1 | -$83.6M | |
| 2 | -$40.4M | |
| 3 | -$29.5M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$11.8M |
| 5 |
Coatue Management
New York
|
-$8.03M |